Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	143.7	172.26	168.69	164.94	180.87	276.9
Short-Term Investments	-	3.41	1.63	-	-	-
Trading Asset Securities	0.71	0.67	0.66	34.65	31.63	61
Cash & Short-Term Investments	144.41	176.34	170.98	199.59	212.5	337.9
Cash Growth	-11.19%	3.13%	-14.33%	-6.08%	-37.11%	-35.12%
Accounts Receivable	55.34	62.95	55.37	108.13	162.65	201.33
Other Receivables	4.51	4.63	10.26	18.93	147.56	2.99
Receivables	59.85	67.58	65.63	127.06	310.21	204.32
Inventory	210.7	297.11	333.5	394.5	440.43	440.32
Other Current Assets	201.46	208.21	245.9	273.31	280.11	262.57
Total Current Assets	616.41	749.24	816	994.46	1,243	1,245
Property, Plant & Equipment	280.15	296.42	281.18	296.92	314.39	129.5
Long-Term Investments	89	89	228.97	270.96	345.14	890.54
Other Intangible Assets	82.21	83.25	84.68	145.78	166.36	109.99
Long-Term Deferred Tax Assets	29.52	31.34	30.83	23	18.97	22.6
Long-Term Deferred Charges	5.89	8.08	2.33	3.13	3.72	11.03
Other Long-Term Assets	101.93	101.99	115.24	113.87	114.33	0
Total Assets	1,205	1,359	1,559	1,848	2,206	2,409
Accounts Payable	15.99	6.77	2.67	3.74	122	2.58
Accrued Expenses	1.6	17.2	9.01	7.21	2.78	4.8
Current Portion of Leases	11.07	8.83	1.95	0.55	-	-
Current Income Taxes Payable	2.24	2.17	-	-	1.3	1.74
Current Unearned Revenue	9.11	40.38	2.31	9.63	1.44	-
Other Current Liabilities	17.42	5.8	5.79	3.59	6.48	6.31
Total Current Liabilities	57.44	81.14	21.73	24.7	133.99	15.44
Long-Term Leases	2.14	9.83	2.95	0.58	-	-
Long-Term Unearned Revenue	0.62	1.01	1.63	2.36	3.09	3.82
Long-Term Deferred Tax Liabilities	-	0	-	-	-	0.45
Other Long-Term Liabilities	-	-	-	-	-	0.43
Total Liabilities	60.2	91.99	26.3	27.64	137.08	20.14
Common Stock	587.06	587.06	587.06	587.06	587.06	587.06
Additional Paid-In Capital	237.37	237.37	237.37	237.37	237.37	237.37
Retained Earnings	350.18	440.63	708.5	996.04	1,245	1,564
Total Common Equity	1,141	1,265	1,533	1,820	2,069	2,389
Minority Interest	4.06	2.25	-0	-	-	-
Shareholders' Equity	1,145	1,267	1,533	1,820	2,069	2,389
Total Liabilities & Equity	1,205	1,359	1,559	1,848	2,206	2,409
Total Debt	13.21	18.66	4.9	1.13	-	-
Net Cash (Debt)	131.2	157.68	166.09	198.46	212.5	337.9
Net Cash Growth	-7.16%	-5.06%	-16.31%	-6.61%	-37.11%	-35.12%
Net Cash Per Share	0.23	0.27	0.28	0.34	0.36	0.58
Filing Date Shares Outstanding	572.36	587.06	587.06	587.06	587.06	587.06
Total Common Shares Outstanding	572.36	587.06	587.06	587.06	587.06	587.06
Working Capital	558.97	668.09	794.28	969.75	1,109	1,230
Book Value Per Share	1.99	2.15	2.61	3.10	3.52	4.07
Tangible Book Value	1,059	1,182	1,448	1,675	1,903	2,279
Tangible Book Value Per Share	1.85	2.01	2.47	2.85	3.24	3.88
Buildings	-	319.75	298.95	301.11	301.11	131.6
Machinery	-	107.22	106.11	105.92	104.33	88.59
Construction In Progress	-	-	1.28	-	-	-

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.